Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Steve Hagan, Jerome Brody, Armin Ernst, Scott Ferguson, and More


HTG Molecular Diagnostics has named Steve Hagan to be vice president of molecular diagnostic sales. Hagan previously was at Ventana Medical Systems, where he was senior director of digital pathology and workflow commercialization.

Allegro Diagnostics has named its clinical and scientific advisory board.

The board members include: Jerome Brody, a professor of medicine and director of the Pulmonary Center at the Boston University School of Medicine; Armin Ernst, a professor of medicine at Tufts School of Medicine and chief of the Division of Pulmonary, Critical Care, and Sleep Medicine at St. Elizabeth's Medical Center; Scott Ferguson, an associate professor at the University of Wisconsin School of Medicine and Public Health; Gerard Silvestri, a professor in the Division of Pulmonary and Critical Care Medicine at the Medical University of South Carolina; Avrum Spira, a professor and chief of the Division of Computational Biomedicine at the Boston University School of Medicine; and Anil Vachani, an assistant professor at the University of Pennsylvania's School of Medicine, Pulmonary, Allergy, and Critical Care Division.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.